Back to search
SAM.govNotice 330a7d73f8e44c2ca588697555e48829

Generative Optogenetics (GO)

Country
United States
Published
December 19, 2025
Deadline
February 26, 2026

Description

{"description":"The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative concepts to design a protein complex that can be expressed in vivo (i.e., in a living cell) and responds to optical signals to synthesize a corresponding DNA or RNA sequence. This technology should enable massless transfer of genetic information to cells expressing the protein complex via a template-free mechanism that incorporates nucleotide bases in response to specific optical signals (e.g., different wavelengths of light). The GO program is focused on two main Research Objectives (ROs): (1) achieving the core capability of synthesizing DNA/RNA directly in living cells using optical signals, and (2) developing error mitigation methods that ensure high-fidelity nucleic acid synthesis. The acquisition process for GO will proceed through a two-stage process, starting with (1) written abstracts which will inform invitations to brief (2) an Oral Proposal Package (OPP) at DARPA."} Solicitation Number: DARPA-PS-26-10 Type: Solicitation Base Type: Solicitation NAICS: 541714 Classification Code: AC12 Response Deadline: 2026-02-26T16:00:00 Office Address: ARLINGTON, VA POC: Dr. Matthew J. Pava, Program Manager, GO@darpa.mil {"description":"The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative concepts to design a protein complex that can be expressed in vivo (i.e., in a living cell) and responds to optical signals to synthesize a corresponding DNA or RNA sequence. This technology should enable massless transfer of genetic information to cells expressing the protein complex via a template-free mechanism that incorporates nucleotide bases in response to specific optical signals (e.g., different wavelengths of light). The GO program is focused on two main Research Objectives (ROs): (1) achieving the core capability of synthesizing DNA/RNA directly in living cells using optical signals, and (2) developing error mitigation methods that ensure high-fidelity nucleic acid synthesis. The acquisition process for GO will proceed through a two-stage process, starting with (1) written abstracts which will inform invitations to brief (2) an Oral Proposal Package (OPP) at DARPA."}

Open original notice

Get tenders like this in one daily alert

Use this notice as context when Tenqual drafts your search scope and fit criteria.

Create free alert
Generative Optogenetics (GO) tender | Tenqual